Fig. 1: Flow of participants in the study.

Patients with psychotic symptoms and missing values of biomarkers were excluded from the participants. As a result, a total of 921 UPD patients and 239 BPD patients participated in the study.

Patients with psychotic symptoms and missing values of biomarkers were excluded from the participants. As a result, a total of 921 UPD patients and 239 BPD patients participated in the study.